Lipid lowering after myocardial infarction in hospital practice

British Journal of Clinical Governance

Volumn 7, Issue 3, 2002, Pages 154-157

  Dutta, D ^a   Ogunnaike, B ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Coronary heart disease; Health; Hospitals

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CORONARY CARE UNIT; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; GENERAL HOSPITAL; HEALTH SURVEY; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NATIONAL HEALTH SERVICE; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; SECONDARY PREVENTION; SEX DIFFERENCE; STANDARD; SURVIVAL;

EID: 0036381987     PISSN: 14664100     EISSN: None     Source Type: Journal    
DOI: 10.1108/14664100210438235     Document Type: Article

References (13)

1. Arntz, H.R. (1999), "Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events", Atherosclerosis, Vol. 147 Supplement 1, pp. s17-s21.
2. Bowker, T.J., Clayton, T.C., Ingham, J., McLennan, N.R., Hobson, H.L., Pyke, S.D. et al. (1996), "A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events)", Heart, Vol. 75, pp. 334-42.
3. Fox, K.A., Cokkinos, D.V., Deckers, J., Keil, U., Maggioni, A. and Steg, G. (2000), "The ENACT study: a pan-European survey of acute coronary syndromes. European network for acute coronary treatment", European Heart Journal, Vol. 21, pp. 1440-9.
4. Hulley, S.B., Grady, D. and Browner, W.S. (2000), "Statins: under-used by those who would benefit", British Medical Journal, Vol. 321, pp. 971-2.
5. Khong, T.K., Missouris, C.G., Murda'h, M. and MacGregor, G.A (1998), "The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice", Postgraduate Medical Journal, Vol. 74, pp. 600-1.
6. Lancet (1994), "Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)", Lancet, Vol. 344, pp. 1383-9.
7. New England Journal of Medicine (1998), "The long-term intervention with pravastatin in ischaemic disease (LIPID) study group: prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels", New England Journal of Medicine, Vol. 339, pp. 1349-57.
8. Pekkanen, J., Linn, S., Heiss, G., Suchindran, C.M., Leon, A., Rifkind, B.M. et al. (1990), "Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without pre-existing cardiiovascular disease", New England Journal of Medicine, Vol. 322, pp. 1700-7.
9. Sacks, F.M., Pfeffer, M.A., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G. et al. (1996), "The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators", New England Journal of Medicine, Vol. 335, pp. 1001-9.
10. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W. et al. (1995), "Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. West of Scotland Coronary Prevention Study Group", New England Journal of Medicine, Vol. 333, pp. 1301-7.
11. Standing Medical Advisory Committee (1997), The Use of Statins, Department of Health, London.
12. Stenestrand, U. and Wallentin, L. (2001), "Early statin treatment following acute myocardial infarction and one-year survival", Journal of the American Medical Association, Vol. 285, pp. 430-6.
13. Wood, D., Durrington, P., Poulter, N., McInnes, G., Rees, A. and Wray, R. (1998), "Joint British recommendations on prevention of coronary heart disease in clinical practice", Heart, Vol. 80 Supplement 2, pp. S1-S29.